Jay Achar

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: IJTLD OPEN. 2024;1(7):285-291

A 10-year review of isoniazid-resistant TB management in Uzbekistan 2009-2020.

Rekart ML; Thit P; Oluya M; Moe S; Hasan T; Parpieva N; Safaev K; Khristusev A; Zinaida T; Singh J; Allamuratova S; Azamat I; Restrepo CG; Sitali N; Achar J; Alvaraez JL; Sinha A
Article: GLOBALIZATION AND HEALTH. 2024;20(1):51

Trends in the availability and prices of quality-assured tuberculosis drugs: a systematic analysis of Global Drug Facility Product Catalogs from 2001 to 2024

Kohler S; Achar J; Mulder C; Sitali N; Paul N
Article: LANCET INFECTIOUS DISEASES. 2024;:S1473-3099(24)00228-7

Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study.

Korotych O; Achar J; Gurbanova E; Hovhannesyan A; Lomtadze N; Ciobanu A; Skrahina A; Dravniece G; Kuksa L; Rich M; Khachatryan N; Germanovych M; Kadyrov A; Terleieva I; Akhundova I; Adenov M; Durdyeva M; Kiria N; Parpieva N; Yatskevich N; Jumayev R; Nurov R; Diktanas S; Vilc V; Migliori GB; Yedilbayev A
Article: IJTLD OPEN. 2024;1(3):103-110

Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European Region.

Migliori GB; Korotych O; Achar J; Ciobanu A; Dravniece G; Germanovych M; Gurbanova E; Hovhannesyan A; Khachatryan N; Kuksa L; Lomtadze N; Rich ML; Skrahina A; Yedilbayev A
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2023;27(10):748-753

Household drug-resistant TB contact tracing in Tajikistan

Rekart ML; Aung A; Cullip T; Mulanda W; Mun L; Pirmahmadzoda B; Kliescokova J; Achar J; Alvarez JL; Sitali N; Sinha A
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2023;27(8):584-598

Clinical standards for drug-susceptible TB in children and adolescents

Chiang SS; Graham SM; Schaaf HS; Marais BJ; Sant'Anna CC; Sharma S; Starke JR; Triasih R; Achar J; Amanullah F; Armitage LY; Aurilio RB; Buck WC; Centis R; Chabala C; Cruz AT; Demers A-M; du Preez K; Enimil A; Furin J; Garcia-Prats AJ; Gonzalez NE; Hoddinott G; Isaakidis P; Jaganath D; Kabra SK; Kampmann B; Kay A; Kitai I; Lopez-Varela E; Maleche-Obimbo E; Malaspina FM; Velasquez JN; Nuttall JJC; Oliwa JN; Andrade IO; Perez-Velez CM; Rabie H; Seddon JA; Sekadde MP; Shen A; Skrahina A; Soriano-Arandes A; Steenhoff AP; Tebruegge M; Tovar MA; Tsogt B; van der Zalm MM; Welch H; Migliori GB
Article: JOURNAL OF PUBLIC HEALTH. 2023;45(2):481-487

Costs and import costs of past, present, and future TB drug regimens: a case study for Karakalpakstan, Uzbekistan

Kohler S; Sitali N; Achar J; Paul N
Article: MICROBIOLOGY SPECTRUM. 2023;11(1):e0369822-e03622

Detection of Mycobacterium tuberculosis Complex Using the Xpert MTB/RIF Ultra Assay on the Stool of Pediatric Patients in Dushanbe, Tajikistan

Rekart ML; Mun L; Aung A; Gomez D; Mulanda W; Kliescikova J; Sitali N; Rajabov A; Azamova S; Pirmahmadzoda B; Achar J; Alvarez JL; Greig J; du Cros P; Sinha A
Article: PLOS GLOBAL PUBLIC HEALTH. 2023;3(4):e0000818

Comparative effectiveness of adding delamanid to a multidrug-resistant tuberculosis regimen comprised of three drugs likely to be effective.

Rodriguez CA; Lodi S; Horsburgh CR; Mitnick CD; Bastard M; Huerga H; Khan U; Rich M; Seung KJ; Atwood S; Manzur-Ul-Alam M; Melikyan N; Mpinda S; Myint Z; Naidoo Y; Petrosyan O; Salahuddin N; Sarfaraz S; Vilbrun SC; Yae K; Achar J; Ahmed S; Algozhina E; Beauchamp J; de Guadelupe Perea Moreno S; Gulanbaeva M; Gergedava M; Indah Sari CY; Hewison C; Khan P; Franke MF
Article: LANCET GLOBAL HEALTH. 2022;10(12):e1774-e1781

Global impact of COVID-19 on childhood tuberculosis: an analysis of notification data

Ranasinghe L; Achar J; Groschel MI; Whittaker E; Dodd PJ; Seddon JA
Article: PLOS GLOBAL PUBLIC HEALTH. 2022;2(8):e0000567

The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, Uzbekistan.

Kohler S; Sitali N; Achar J; Paul N
Article: ERJ OPEN RESEARCH. 2022;8(1):622-2021

Programme costs of longer and shorter tuberculosis drug regimens and drug import: a modelling study for Karakalpakstan, Uzbekistan

Kohler S; Sitali N; Achar J; Paul N
Article: TROPICAL MEDICINE & INTERNATIONAL HEALTH. 2021;26(4):421-427

Accuracy of molecular drug susceptibility testing amongst tuberculosis patients in Karakalpakstan, Uzbekistan

Gil H; Margaryan H; Azamat I; Ziba B; Bayram H; Nazirov P; Gomez D; Singh J; Zayniddin S; Parpieva N; Achar J
Article: MONALDI ARCHIVES FOR CHEST DISEASE. 2021;91(1)

Factors associated with culture conversion among adults treated for pulmonary extensively drug-resistant tuberculosis during 2018-2019 in the Russian Federation: an observational cohort study

Russkikh A; Korotych O; Sereda Y; Samoilova A; Achar J; Yedilbayev A; Dara M; Vasilyeva I
Article: MONALDI ARCHIVES FOR CHEST DISEASE. 2021;91(1)

Factors associated with time to sputum culture conversion of rifampicin-resistant tuberculosis patients in Klaipeda, Lithuania in 2016-2019: a cohort study

Diktanas S; Korotych O; Sereda Y; Gozalov O; Rubcova O; Achar J
Article: ERJ OPEN RESEARCH. 2021;7(1):537-2020

Outcomes with a shorter multidrugresistant tuberculosis regimen from Karakalpakstan, Uzbekistan

du Cros P; Khamraev A; Tigay Z; Abdrasuliev T; Greig J; Cooke G; Herboczek K; Pylypenko T; Berry C; Ronnachit A; Lister D; Dietrich S; Ariti C; Safaev K; Nyang'wa B-T; Parpieva N; Tillashaikhov M; Achar J
Article: BMC INFECTIOUS DISEASES. 2020;20(1):675

Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan

Horter S; Stringer B; Gray N; Parpieva N; Safaev K; Tigay Z; Singh J; Achar J
Article: EUROPEAN RESPIRATORY JOURNAL. 2020;55(3):1901467

Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

Abidi S; Achar J; Neino MMA; Bang D; Benedetti A; Brode S; Campbell JR; Casas EC; Conradie F; Dravniece G; du Cros P; Falzon D; Jaramillo E; Kuaban C; Lan Z; Lange C; Li PZ; Makhmudova M; Maug AKJ; Menzies D; Migliori GB; Miller A; Myrzaliev B; Ndjeka N; Noeske J; Parpieva N; Piubello A; Schwoebel V; Sikhondze W; Singla R; Souleymane MB; Trebucq A; Van Deun A; Viney K; Weyer K; Zhang BJ; Khan FA
Article: PLOS ONE. 2020;15(11):e0242359

Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan

Horter S; Achar J; Gray N; Parpieva N; Tigay Z; Singh J; Stringer B
Article: PLOS MEDICINE. 2018;15(7):e1002591

Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis

Harausz EP; Garcia-Prats AJ; Law S; Schaaf HS; Kredo T; Seddon JA; Menzies D; Turkova A; Achar J; Amanullah F; Barry P; Becerra M; Chan ED; Chan PC; Chiotan DI; Crossa A; Drobac PC; Fairlie L; Falzon D; Flood J; Gegia M; Hicks RM; Isaakidis P; Kadri SM; Kampmann B; Madhi SA; Marais E; Mariandyshev A; Mendez-Echevarria A; Moore BK; Nargiza P; Ozere I; Padayatchi N; Saleem-ur-Rehman; Rybak N; Santiago-Garcia B; Shah NS; Sharma S; Shim TS; Skrahina A; Soriano-Arandes A; van den Boom M; van der Werf MJ; van der Werf TS; Williams B; Yablokova E; Yim J-J; Furin J; Hesseling AC
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2018;22(5):544-550

Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan

Kuhlin J; Smith C; Khaemraev A; Tigay Z; Parpieva N; Tillyashaykhov M; Achar J; Hajek J; Greig J; du Cros P; Moore D
Article: EMERGING INFECTIOUS DISEASES. 2017;23(10):1711-1713

Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis

Achar J; Hewison C; Cavalheiro AP; Skrahina A; Cajazeiro J; Nargiza P; Herboczek K; Rajabov AS; Hughes J; Ferlazzo G; Seddon JA; du Cros P
Article: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2017;20(Suppl 4):21654

Delivering HIV care in challenging operating environments: the MSF experience towards differentiated models of care for settings with multiple basic health care needs

Ssonko C; Gonzalez L; Mesic A; da Fonseca MS; Achar J; Safar N; Martin B; Wong S; Casas EC
Article: PLOS ONE. 2017;12(5):e0176692

Ebola management centre proximity associated with reduced delays of healthcare of Ebola Virus Disease (EVD) patients, Tonkolili, Sierra Leone, 2014-15

Theocharopoulos G; Danis K; Greig J; Hoffmann A; De Valk H; Jimissa A; Tejan S; Sankoh M; Kleijer K; Turner W; Achar J; Duncombe J; Lokuge K; Gayton I; Broeder R; Kremer R; Caleo G
Article: BMC MEDICINE. 2016;14(1):187

Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

Trauer JM; Achar J; Parpieva N; Khamraev A; Denholm JT; Falzon D; Jaramillo E; Mesic A; du Cros P; McBryde ES
Journal article: F1000RESEARCH. 2016;5:1477

Electronic medical records in humanitarian emergencies – the development of an Ebola clinical information and patient management system

Jobanputra K; Greig J; Shankar G; Perakslis E; Kremer R; Achar J; Gayton I
Article: LANCET GLOBAL HEALTH. 2016;4(7):e495-e501

Inpatient signs and symptoms and factors associated with death in children aged 5 years and younger admitted to two Ebola management centres in Sierra Leone, 2014: a retrospective cohort study

Shah T; Greig J; van der Plas LM; Achar J; Caleo G; Squire JS; Turay AS; Joshy G; D'Este C; Banks E; Vogt F; Lokuge K
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2016;20(4):474-478

Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications

Swaminathan A; du Cros P; Seddon JA; Quinnell S; Bobokhojaev OI; Dusmatova Z; Achar J
Article: EMERGING INFECTIOUS DISEASES. 2016;22(2):217-223

Prognostic Indicators for Ebola Patient Survival

Crowe SJ; Maenner MJ; Kuah S; Erickson BR; Coffee M; Knust B; Klena J; Foday J; Hertz D; Hermans V; Achar J; Caleo GM; Van Herp M; Albarino CG; Amman B; Basile AJ; Bearden S; Belser JA; Bergeron E; Blau D; Brault AC; Campbell S; Flint M; Gibbons A; Goodman C; McMullan L; Paddock C; Russell B; Selzer JS; Sanchez A; Sealy T; Wang D; Saffa G; Turay A; Nichol ST; Towner JS
Article: F1000RESEARCH. 2016;5:1477

Electronic medical records in humanitarian emergencies - the development of an Ebola clinical information and patient management system.

Jobanputra K; Greig J; Shankar G; Perakslis E; Kremer R; Achar J; Gayton I
Visa fler

Alla övriga publikationer

Letter: EUROPEAN RESPIRATORY JOURNAL. 2023;62(5):2300969

Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing

Achar J; Seddon JA; Knight GM; Dodd PJ; Esmail H; Hughes J; Mcquaid CF
Review: PATHOGENS. 2022;11(4):381

Treatment of Rifampicin-Resistant Tuberculosis Disease and Infection in Children: Key Updates, Challenges and Opportunities

Howell P; Achar J; Huang GKL; Mariandyshev A; Schaaf HS; Garcia-Prats AJ
Review: BMC INFECTIOUS DISEASES. 2020;20(1):298

A case report of a child with probable drug resistant tuberculous pericarditis with a review of challenges involved in diagnosis, treatment and follow up of children with DR-TB pericarditis

Swaminathan A; du Cros P; Achar J; Kliescikova J; Mirgayosieva S; Pirmahmadzoda B
Review: EMERGING INFECTIOUS DISEASES. 2019;25(3):441-450

Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis

Osman M; Harausz EP; Garcia-Prats AJ; Schaaf HS; Moore BK; Hicks RM; Achar J; Amanullah F; Barry P; Becerra M; Chiotan DI; Drobac PC; Flood J; Furin J; Gegia M; Isaakidis P; Mariandyshev A; Ozere I; Shah NS; Skrahina A; Yablokova E; Seddon JA; Hesseling AC
Review: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2017;195(10):1300-1310

New and Repurposed Drugs for Pediatric Multidrug-Resistant Tuberculosis Practice-based Recommendations

Harausz EP; Garcia-Prats AJ; Seddon JA; Schaaf HS; Hesseling AC; Achar J; Bernheimer J; Cruz AT; D'Ambrosio L; Detjen A; Graham SM; Hughes J; Jonckheere S; Marais BJ; Migliori GB; McKenna L; Skrahina A; Tadolini M; Wilson P; Furin J
Letter: LANCET. 2016;388(10057):2234

WHO recommendations for multidrug-resistant tuberculosis

Berry C; Achar J; du Cros P
Letter: EMERGING INFECTIOUS DISEASES. 2015;21(11):2105-2106

Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen

Achar J; Berry C; Herboczek K; Parpieva N; Tillyashaykhov MN; Tigay ZN; Khamraev A; Velivela K; Seddon JA; du Cros P
Review: OBSTETRIC MEDICINE. 2015;8(3):108-113

Ebola viral disease and pregnancy.

Black BO; Caluwaerts S; Achar J

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI